Profil
Dr. De Kimpe Sjef is a Venture Partner at Atheneos Ventures LLC.
Dr. Sjef was previously employed as a Vice President-Early Drug Development by Prosensa Holding NV.
He received his graduate degree from the University of Utrecht, an MBA from the University of Tilburg, an MBA from TiasNimbas Business School BV, a doctorate degree from the University of Utrecht and a doctorate degree from TiasNimbas Business School BV.
Postes actifs de Sjef de Kimpe
| Sociétés | Poste | Début |
|---|---|---|
Atheneos Ventures LLC
Atheneos Ventures LLC Investment ManagersFinance Atheneos Ventures invests in companies located in the United States. The firm targets companies operating in the pharmaceutical, biotech, medical device, diagnostics and therapeutic foods sectors. It provides financing for early stage capital requirements. | Private Equity Investor | 01/11/2017 |
Anciens postes connus de Sjef de Kimpe
| Sociétés | Poste | Fin |
|---|---|---|
| PROSENSA HOLDING NV | Private Equity Investor | 01/01/2015 |
Formation de Sjef de Kimpe
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
University of Tilburg
University of Tilburg Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Utrecht
University of Utrecht Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Prosensa Holding NV
Prosensa Holding NV BiotechnologyHealth Technology Engages in the development of ribonucleic acid-modulating or RNA-modulating, therapeutics for the treatment of genetic disorders | Health Technology |
TiasNimbas Business School BV
TiasNimbas Business School BV Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Atheneos Ventures LLC
Atheneos Ventures LLC Investment ManagersFinance Atheneos Ventures invests in companies located in the United States. The firm targets companies operating in the pharmaceutical, biotech, medical device, diagnostics and therapeutic foods sectors. It provides financing for early stage capital requirements. | Finance |
















